Ultraweak Pulsed EMF for Erectile Dysfunction via Potassium Channel Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Erectile dysfunction (ED) remains a challenging condition due to impaired relaxation of corporal smooth muscle cells, which is not adequately addressed by existing treatments, particularly in cases where nitric oxide release is defective or affected by aging or disease states, leading to insufficient efficacy and systemic side effects with current pharmacological interventions.
Innovation Solution
The application of ultraweak, pulsed electromagnetic fields of low frequency (around 15.9-16 Hz) directly to the penis, which activates potassium channels and reduces calcium ion entry into smooth muscle cells, promoting vascular dilation and relaxation, effectively mimicking the action of potassium channel openers without systemic side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If phosphodiesterase inhibitors (e.g., sildenafil) are used to improve erectile function, then smooth muscle relaxation is enhanced, but systemic side effects occur and efficacy is limited in cases with defective nitric oxide release
Solution Approach 1:
The electromagnetic field apparatus is designed to deliver localized treatment specifically to the penile region through a transducer that contacts or approaches the penis. The magnetic field is confined to a small volume around the penis, creating a localized therapeutic effect without systemic distribution. This resolves the contradiction by achieving reliable erectile function improvement through local action while avoiding systemic side effects that plague oral pharmacological agents.
Solution Approach 2:
The invention replaces the chemical/pharmacological mechanism (phosphodiesterase inhibition) with a physical mechanism (electromagnetic field action). Instead of using chemicals that circulate systemically and cause side effects, the treatment uses externally applied magnetic fields that act locally on ion channels in penile smooth muscle cells. This substitution of mechanism resolves the contradiction between efficacy and systemic side effects.
2Reliability
If phosphodiesterase inhibitors are used to potentiate erection, then some patients experience improved erectile function, but many patients do not respond due to defective nitric oxide release with aging or disease
Solution Approach 1:
Instead of trying to enhance nitric oxide release (the conventional approach of PDE inhibitors which depend on NO availability), the invention takes the opposite approach by directly acting on potassium channels to hyperpolarize smooth muscle cells and induce relaxation independently of the nitric oxide pathway. This inverted mechanism resolves the contradiction by achieving reliable response across diverse patient populations including those with defective NO release, while the mechanism's simplicity enhances its adaptability.
Solution Approach 2:
The invention changes the therapeutic parameter from pharmacological concentration of PDE inhibitors to physical parameters of electromagnetic field (frequency, amplitude, pulse duration). By tuning these physical parameters, the treatment can be optimized for different patient conditions and disease states, achieving both high response rate and broad adaptability across aging populations and various disease states affecting erectile function.
3Reliability
If potassium channel openers are used to induce smooth muscle relaxation, then vascular dilation and erection are promoted, but the drugs must be administered systemically which causes side effects
Solution Approach 1:
The invention replaces systemic drug administration with localized electromagnetic field application. The magnetic field directly activates potassium channels in penile smooth muscle cells through its physical interaction with ion channels, achieving the same physiological effect (hyperpolarization and relaxation) without requiring systemic drug circulation. This resolves the contradiction by maintaining reliable smooth muscle relaxation efficacy while eliminating systemic side effects.
Solution Approach 2:
The electromagnetic field transducer is designed to deliver treatment locally to the penis, confining the therapeutic effect to the target organ. The magnetic field intensity is sufficient to activate potassium channels in the penile region but does not require systemic distribution. This localized quality approach resolves the contradiction between achieving reliable smooth muscle relaxation and avoiding systemic side effects from drug administration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases penile blood flow, leading to improved erectile function in most patients, with favorable results demonstrated in both animal and human studies, and can be used in conjunction with existing treatments like sildenafil for enhanced efficacy.
Implementation Method 1
it is believed that the application of a pulsed, ultraweak electromagnetic field to the penis potentates erection by affecting the K+ and Ca2+ channels, inducing them to change their conformation by moving from one certain state (activation) to another (inactivation), or vice versa
Data Source
AI summary
An apparatus and method for treating erectile dysfunction by using a pulsating, ultraweak, magnetic field. A transducer generates an ultraweak, pulsating magnetic fields which is applied to the penis, which as a result of the magnetic field causes the erection of the penis. Another aspect of the invention is an apparatus and method for treating medical conditions in women by using a pulsating, ultraweak, magnetic field.